Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 22, 2025 08:00 ET | Source: BlossomHill Therapeutics, Inc.

BlossomHill Therapeutics Announces First Patient Dosed in Expansion Cohorts of the Phase 1/2 SOLARA Trial, Evaluating BH-30643 in Advanced EGFR-mutant Non-Small Cell Lung Cancer

BlossomHill Therapeutics, Inc. today announced the first patient dosed in the expansion cohorts of the SOLARA trial, the first-in-human trial of BH-30643.
March 02, 2021 16:02 ET | Source: Sorrento Therapeutics, Inc.

Sorrento Receives US FDA Clearance to Proceed With Phase 1 Study for STI-2099 (Intranasal COVIDROPS) in Healthy Volunteers and Outpatient Treatment for Newly Diagnosed COVID-19 Positive Patients

FDA granted IND clearance today for the commencement of a Phase 1 safety and pharmacokinetic study for STI-2099 (COVIDROPS™) in healthy volunteers and outpatients with mild COVID-19 disease with or...
January 19, 2021 17:06 ET | Source: Sorrento Therapeutics, Inc.

Sorrento to Present Data Demonstrating STI-2020 Preserves Binding Against UK B.1.1.7 SARS-CoV-2 Mutated Spike Protein

SAN DIEGO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced that it will be presenting preliminary results from an ongoing SARS-CoV-2 mutation...
April 03, 2019 07:38 ET | Source: Precipio, Inc.

Precipio’s HemeScreen™ Adopted by Methodist Health

NEW HAVEN, Conn., April 03, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that Methodist Hospital, located in Memphis, TN, has selected...
September 20, 2018 07:37 ET | Source: Precipio, Inc.

Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering

New kit examines most relevant EGFR exons that impact therapeutic decisions for lung cancer patients NEW HAVEN, Conn., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO), announced...
March 03, 2016 12:36 ET | Source: ARUP Laboratories

New Genetic Mutation Discovery Sheds Light on Anemia Disease

SALT LAKE CITY, March 3, 2016 (GLOBE NEWSWIRE) -- Using whole exome sequencing, which sequences all expressed genes in a genome, Rong Mao, MD, and Pinar Bayrak-Toydemir, MD, PhD, discovered a new...
November 05, 2015 15:18 ET | Source: ARUP Laboratories

Breakthrough Technology Spurs New Test for Non-Small Cell Lung Cancer Patients

SALT LAKE CITY, Nov. 5, 2015 (GLOBE NEWSWIRE) -- For a patient battling lung cancer, the discomforts and risks of undergoing repeated biopsies, surgeries, and radiologic scans can now be replaced by a...
July 16, 2013 00:01 ET | Source: Invivoscribe

Invivoscribe FLT3 Method Patent Claims Upheld

SAN DIEGO, CA--(Marketwired - Jul 16, 2013) - Invivoscribe Technologies, Inc. ("Invivoscribe") has successfully defended the method claims at the core of international patents covering FLT3...
May 14, 2013 00:01 ET | Source: Invivoscribe Technologies, Inc.

Invivoscribe Prevails in German District Court (FLT3 Patent Infringement Action)

SAN DIEGO, CA--(Marketwired - May 14, 2013) - MLL Münchner Leukämielabor GmbH ("MLL") Laboratories has been found guilty of patent infringement in a matter involving FLT3 testing patent...
March 24, 2011 17:30 ET | Source: Biolog, Inc.

Differentiation and Mutation Changes in Mammalian Cells of Shared Lineage Determined With Assay Method That Measures Multiple Energy-Producing Pathways

HAYWARD, CA--(Marketwire - March 24, 2011) - In a paper published today in the journal PLoS ONE, researchers from Biolog, Inc., and the Broad Institute of Harvard & MIT describe the...